101 related articles for article (PubMed ID: 12574669)
1. Short-term effects of improved glycemic control on cognitive function in patients with type 2 diabetes.
Hewer W; Mussell M; Rist F; Kulzer B; Bergis K
Gerontology; 2003; 49(2):86-92. PubMed ID: 12574669
[TBL] [Abstract][Full Text] [Related]
2. Effects of improved glycaemic control maintained for 3 months on cognitive function in patients with Type 2 diabetes.
Mussell M; Hewer W; Kulzer B; Bergis K; Rist F
Diabet Med; 2004 Nov; 21(11):1253-6. PubMed ID: 15498095
[TBL] [Abstract][Full Text] [Related]
3. Verbal learning and/or memory improves with glycemic control in older subjects with non-insulin-dependent diabetes mellitus.
Gradman TJ; Laws A; Thompson LW; Reaven GM
J Am Geriatr Soc; 1993 Dec; 41(12):1305-12. PubMed ID: 8227912
[TBL] [Abstract][Full Text] [Related]
4. The effect of improved glycemic control on cognitive functions in the elderly patient with diabetes.
Meneilly GS; Cheung E; Tessier D; Yakura C; Tuokko H
J Gerontol; 1993 Jul; 48(4):M117-21. PubMed ID: 8315222
[TBL] [Abstract][Full Text] [Related]
5. Effects of intensified metabolic control on CNS function in type 2 diabetes.
Cooray G; Nilsson E; Wahlin A; Laukka EJ; Brismar K; Brismar T
Psychoneuroendocrinology; 2011 Jan; 36(1):77-86. PubMed ID: 20656408
[TBL] [Abstract][Full Text] [Related]
6. Humalog Mix 25 in patients with type 2 diabetes which do not achieve acceptable glycemic control with oral agents: results from a phase III, randomized, parallel study.
Tîrgovişte CI; Străchinariu R; Farcaşiu E; Milicevic Z; Teodorescu G
Rom J Intern Med; 2003; 41(2):153-62. PubMed ID: 15526500
[TBL] [Abstract][Full Text] [Related]
7. Relationships between daily acute glucose fluctuations and cognitive performance among aged type 2 diabetic patients.
Rizzo MR; Marfella R; Barbieri M; Boccardi V; Vestini F; Lettieri B; Canonico S; Paolisso G
Diabetes Care; 2010 Oct; 33(10):2169-74. PubMed ID: 20573753
[TBL] [Abstract][Full Text] [Related]
8. Continuous glucose monitoring: physiologic and pathophysiologic significance.
Ionescu-Tîrgovişte C; Guja C; Ioacără S; Dumitrescu D; Tomescu I
Rom J Intern Med; 2004; 42(2):381-93. PubMed ID: 15529628
[TBL] [Abstract][Full Text] [Related]
9. Lower cognitive performance among long-term type 1 diabetes survivors: A case-control study.
Awad A; Lundqvist R; Rolandsson O; Sundström A; Eliasson M
J Diabetes Complications; 2017 Aug; 31(8):1328-1331. PubMed ID: 28579311
[TBL] [Abstract][Full Text] [Related]
10. Severe hypoglycemia is associated with antidiabetic oral treatment compared with insulin analogs in nursing home patients with type 2 diabetes and dementia: results from the DIMORA study.
Abbatecola AM; Bo M; Barbagallo M; Incalzi RA; Pilotto A; Bellelli G; Maggi S; Paolisso G;
J Am Med Dir Assoc; 2015 Apr; 16(4):349.e7-12. PubMed ID: 25669671
[TBL] [Abstract][Full Text] [Related]
11. Continuous glucose monitoring and cognitive performance in type 2 diabetes.
Pearce KL; Noakes M; Wilson C; Clifton PM
Diabetes Technol Ther; 2012 Dec; 14(12):1126-33. PubMed ID: 23046398
[TBL] [Abstract][Full Text] [Related]
12. Fatigue and cognitive symptoms in patients with diabetes: relationship with disease phenotype and insulin treatment.
Lasselin J; Layé S; Barreau JB; Rivet A; Dulucq MJ; Gin H; Capuron L
Psychoneuroendocrinology; 2012 Sep; 37(9):1468-78. PubMed ID: 22370460
[TBL] [Abstract][Full Text] [Related]
13. Changes in cognitive abilities over a 4-year period are unfavorably affected in elderly diabetic subjects: results of the Epidemiology of Vascular Aging Study.
Fontbonne A; Berr C; Ducimetière P; Alpérovitch A
Diabetes Care; 2001 Feb; 24(2):366-70. PubMed ID: 11213894
[TBL] [Abstract][Full Text] [Related]
14. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.
Houthoofd SA; Morrens M; Sabbe BG
Clin Ther; 2008 Sep; 30(9):1565-89. PubMed ID: 18840365
[TBL] [Abstract][Full Text] [Related]
15. Premeal insulin lispro plus bedtime NPH or twice-daily NPH in patients with type 2 diabetes: acute postprandial and chronic effects on glycemic control and cardiovascular risk factors.
Ceriello A; Del Prato S; Bue-Valleskey J; Beattie S; Gates J; de la Peña A; Malone J
J Diabetes Complications; 2007; 21(1):20-7. PubMed ID: 17189870
[TBL] [Abstract][Full Text] [Related]
16. Short-term intensive glycemic control improves vibratory sensation in type 2 diabetes.
Fujita Y; Fukushima M; Suzuki H; Taniguchi A; Nakai Y; Kuroe A; Yasuda K; Hosokawa M; Yamada Y; Inagaki N; Seino Y
Diabetes Res Clin Pract; 2008 Apr; 80(1):e16-9. PubMed ID: 18262304
[TBL] [Abstract][Full Text] [Related]
17. Glucoregulation has greater impact on cognitive performance than macro-vascular disease in men with type 2 diabetes: data from the Caerphilly study.
Gallacher JE; Pickering J; Elwood PC; Bayer AJ; Yarnell JW; Ben-Shlomo Y
Eur J Epidemiol; 2005; 20(9):761-8. PubMed ID: 16170659
[TBL] [Abstract][Full Text] [Related]
18. [Augmentation of myocardial function by improved glycemic control in patients with type 2 diabetes mellitus].
von Bibra H; Siegmund T; Hansen A; Jensen J; Schumm-Draeger PM
Dtsch Med Wochenschr; 2007 Apr; 132(14):729-34. PubMed ID: 17393343
[TBL] [Abstract][Full Text] [Related]
19. [Nutritional and metabolic status and dietetic evaluation in institutionalized elderly patients with non-insulin-dependent diabetes mellitus].
Casimiro C; García de Lorenzo A; Usán L;
Nutr Hosp; 2001; 16(3):104-11. PubMed ID: 11475679
[TBL] [Abstract][Full Text] [Related]
20. Acute hyperglycemia alters mood state and impairs cognitive performance in people with type 2 diabetes.
Sommerfield AJ; Deary IJ; Frier BM
Diabetes Care; 2004 Oct; 27(10):2335-40. PubMed ID: 15451897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
